Neurofibromatosis - Diagnostic Assessment

作者: Snia Costa , Raquel Tojal , Ana Valverde

DOI: 10.5772/28503

关键词: Peripheral nervous systemDiseaseDiagnostic assessmentMedical geneticsNeurofibromaMedicinePeripheral Nerve SheathPathologyNervous systemNeurofibromatosis

摘要: Descriptions of individuals supposed to have neurofibromatosis been discovered in manuscripts dating from 1000 AD (Zanca, 1980). However, it was not until 1881 that Von Recklinghausen coined the term ‘‘neurofibroma’’ when he observed this benign tumour arose peripheral nerve sheath. His colleagues honored his contribution by naming condition Recklinghausen’s disease. different forms were separated and delineated latter part twentieth century (Ferner et al., 2007a). Neurofibromatosis is one called “neurocutaneous disorders” or “phakomatoses”, genetic diseases involve both skin nervous system. They share some features: hereditary transmission, involvement organs ectodermal origin a tendency develop certain types central system tumours. Advances clinical genetics allowed separate two diseases, each caused gene, although recognition still requires an appreciation cutaneous systemic symptoms. 2007a, 2010)

参考文章(92)
J G Hall, Genomic imprinting: review and relevance to human diseases. American Journal of Human Genetics. ,vol. 46, pp. 857- 873 ,(1990)
J F Gusella, M M MacCollin, D M Parry, M I Kaiser-Kupfer, K Pulaski, M Bolesta, H S Nicholson, R Eldridge, Germ-line mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities. American Journal of Human Genetics. ,vol. 59, pp. 529- 539 ,(1996)
Maryellen M. Daston, Heidi Scrable, Michael Nordlund, Anne K. Sturbaum, Lisa M. Nissen, Nancy Ratner, The protein product of the neurofibromatosis type 1 gene is expressed at highest abundance in neurons, Schwann cells, and oligodendrocytes Neuron. ,vol. 8, pp. 415- 428 ,(1992) , 10.1016/0896-6273(92)90270-N
A. H. Crawford, Nancy Bagamery, Osseous manifestations of neurofibromatosis in childhood. Journal of Pediatric Orthopaedics. ,vol. 6, pp. 72- 88 ,(1986) , 10.1097/01241398-198601000-00015
Marta Pérez-Grau, Núria Miró, José Prades, Juan Vergés, Susana Lareo, Francesc Roca-Ribas, Neurofibromatosis type 2 Acta Otorrinolaringologica (English Edition). ,vol. 61, pp. 306- 311 ,(2010) , 10.1016/S2173-5735(10)70054-5
Sven Bogdan, Christian Klämbt, Epidermal growth factor receptor signaling. Current Biology. ,vol. 11, ,(2001) , 10.1016/S0960-9822(01)00167-1
SK Selvanathan, A Shenton, R Ferner, AJ Wallace, SM Huson, RT Ramsden, DG Evans, Further genotype – phenotype correlations in neurofibromatosis 2 Clinical Genetics. ,vol. 77, pp. 163- 170 ,(2009) , 10.1111/J.1399-0004.2009.01315.X
D G Evans, D Bourn, A Wallace, R T Ramsden, J D Mitchell, T Strachan, Diagnostic issues in a family with late onset type 2 neurofibromatosis. Journal of Medical Genetics. ,vol. 32, pp. 470- 474 ,(1995) , 10.1136/JMG.32.6.470
Nevada Reed, David H. Gutmann, Tumorigenesis in neurofibromatosis: new insights and potential therapies Trends in Molecular Medicine. ,vol. 7, pp. 157- 162 ,(2001) , 10.1016/S1471-4914(01)01955-4
D Barker, E Wright, K Nguyen, L Cannon, P Fain, D Goldgar, DT Bishop, J Carey, B Baty, J Kivlin, H Willard, JS Waye, G Greig, L Leinwand, Y Nakamura, P O'Connell, M Leppert, J-M Lalouel, R White, M Skolnick, Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17 Science. ,vol. 236, pp. 1100- 1102 ,(1987) , 10.1126/SCIENCE.3107130